SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-05-004402
Filing Date
2005-01-24
Accepted
2005-01-24 15:49:20
Documents
2
Period of Report
2005-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3134
2 POA DOCUMENT poa.txt EX-24.3_69716 1736
  Complete submission text file 0001209191-05-004402.txt   6964
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747
Business Address 631-962-2000
LUNDEMOSE ANKER MD, PH.D, DSC (Reporting) CIK: 0001314821 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15190 | Film No.: 05544435